Category:

Policy

Assam private hospitals directed no COVID-19 patient be refused admission for having health insurance

The Health and Family Welfare Department said that it has received reports of some private hospitals refusing admission to COVID-19 patients despite having medical insurance.It referred to an order by the Insurance Regulatory and Development Authority of India (IRDA) in March last year that removed all hurdles in the policies and had directed that the cases should be handled expeditiously.

read more

Will take action if digital crowd funding platform for rare diseases not made operational:HC

The court was hearing a batch of petitions on behalf of children suffering from rare diseases, including Duchenne Muscular Dystrophy (DMD) and Mucopolysaccharidosis II or MPS II (Hunter Syndrome), and seeking direction to the Centre to provide them uninterrupted and free of cost treatment as the therapy is very expensive.

read more

India accounted for highest number of govt requests for account info in Jul-Dec 2020: Twitter

India also ranked second in terms of volume of legal demands for content removal, after Japan, Twitter — which has an estimated 1.75 crore users in India — recently appointed a Resident Grievance Officer, days after it designated a Chief Compliance Officer, and also released its first India Transparency Report on Sunday to comply with the new IT rules.

read more

China tightens control over cybersecurity in data crackdown

Beijing is increasingly sensitive about control over information about its people and economy. Companies are barred from storing data about Chinese customers outside China. Companies including ride-hailing service Didi Global Inc, which recently made its US stock market debut, have been publicly warned to tighten data security.

Under the new rules, anyone in China who finds a vulnerability must tell the government, which will decide what repairs to make. No information can be given to “overseas organisations or individuals” other than the product’s manufacturer.

read more

Medicare evaluating coverage for $56,000 Alzheimer’s drug

“We want to consider Medicare coverage of new treatments very carefully in light of the evidence available. Our process will include opportunities to hear from many stakeholders, including patient advocacy groups, medical experts, states, issuers, industry professionals, and family members and caregivers of those living with this disease” CMS( Centers for Medicare and Medicaid Services) Administrator Chiquita Brooks-LaSure said in a statement

read more